rs6348
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001044.5(SLC6A3):c.810C>T(p.Ala270=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.014 in 1,613,388 control chromosomes in the GnomAD database, including 2,576 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.073 ( 1319 hom., cov: 33)
Exomes 𝑓: 0.0079 ( 1257 hom. )
Consequence
SLC6A3
NM_001044.5 synonymous
NM_001044.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.44
Genes affected
SLC6A3 (HGNC:11049): (solute carrier family 6 member 3) This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 5-1420686-G-A is Benign according to our data. Variant chr5-1420686-G-A is described in ClinVar as [Benign]. Clinvar id is 470642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-1420686-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=2.43 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.247 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A3 | NM_001044.5 | c.810C>T | p.Ala270= | synonymous_variant | 6/15 | ENST00000270349.12 | NP_001035.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A3 | ENST00000270349.12 | c.810C>T | p.Ala270= | synonymous_variant | 6/15 | 1 | NM_001044.5 | ENSP00000270349 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0725 AC: 11038AN: 152180Hom.: 1321 Cov.: 33
GnomAD3 genomes
AF:
AC:
11038
AN:
152180
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0199 AC: 4979AN: 250576Hom.: 568 AF XY: 0.0146 AC XY: 1986AN XY: 135618
GnomAD3 exomes
AF:
AC:
4979
AN:
250576
Hom.:
AF XY:
AC XY:
1986
AN XY:
135618
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00791 AC: 11560AN: 1461090Hom.: 1257 Cov.: 33 AF XY: 0.00697 AC XY: 5066AN XY: 726794
GnomAD4 exome
AF:
AC:
11560
AN:
1461090
Hom.:
Cov.:
33
AF XY:
AC XY:
5066
AN XY:
726794
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0725 AC: 11049AN: 152298Hom.: 1319 Cov.: 33 AF XY: 0.0698 AC XY: 5200AN XY: 74480
GnomAD4 genome
AF:
AC:
11049
AN:
152298
Hom.:
Cov.:
33
AF XY:
AC XY:
5200
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
42
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2018 | - - |
Parkinsonism-dystonia, infantile Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at